Stanford RNA Medicine Program

Advancing RNA biology and therapeutics—R&D, translating discoveries into clinical applications, and training the next generation of RNA leaders.

[Stanford RNA Medicine Program @StanfordRNAMed]

We’re proud to welcome @ThermoFisher as a symposium sponsor!

Explore their end-to-end Advanced Therapeutics capabilities—spanning plasmids, oligo synthesis, IVT, mRNA purification, & LNP characterization.

Connect with their team: https://t.co/jvVDwGxv6L

#mRNA #Biotech

[Stanford RNA Medicine Program @StanfordRNAMed]

We're excited to welcome @moderna_tx as a sponsor for our upcoming 2026 symposium! A pioneer in mRNA medicine, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases.

Learn more: https://t.co/TNVMrWRpQu

#mRNAMedicine #Biotech #Stanford

[Stanford RNA Medicine Program @StanfordRNAMed]

The date is fast approaching! Join top leaders in #RNA therapeutics at the 2026 #Stanford RNA Medicine Symposium on Oct 29th in Palo Alto, CA. Keynotes include Nobel Laureate Jennifer Doudna (#UCBerkeley) and Daniel Anderson (#MIT).

Register: https://t.co/Di2CYf9wZt

[Stanford RNA Medicine Program @StanfordRNAMed]

We’re excited to share a new preprint from RAMP on LNP formulation for spleen-targeted RNA delivery led by our scientist Kseniia Vlasova and Cytiva’s Anitha Thomas. We’re grateful to the Cytiva team and @HowardYChang for supporting this work.
#LNP #RNA
https://t.co/gztpgvOXsa

[Stanford RNA Medicine Program @StanfordRNAMed]

RAMP invites you to the 2026 Stanford RNA Medicine Symposium on October 29 in Palo Alto, CA, bringing together thought-leaders in #RNA therapeutics. Keynotes this year are Nobel Laureate Jennifer Doudna (#UCBerkeley) and Daniel Anderson (#MIT).
Register:
https://t.co/Xqp2CPgTJB

[Stanford RNA Medicine Program @StanfordRNAMed]

New in @Nature: Schiffers et al. establish ac4C as a high-fidelity alternative to m1Ψ for mRNA therapeutics. By doubling translation elongation speeds and bypassing ribosome collisions, ac4C modification ensures superior protein yield and accuracy.
#mRNA
https://t.co/RPjohYPiPr

[Stanford RNA Medicine Program @StanfordRNAMed]

What is the future of #CRISPR and AI in medicine?
Stanford RNA Medicine Symposium Keynote Speaker Dr. Jennifer Doudna joins @emilychangtv on Bloomberg Originals to discuss the next frontier of biotech.

Watch: https://t.co/0KaTGEa8CC

[Stanford RNA Medicine Program @StanfordRNAMed]

Nature Communications: Research reveals how extracellular vesicles distort LNP protein corona profiles. Precision depletion is essential to identify genuine interactomes like ApoE for targeted mRNA delivery.
#LNP #DrugDelivery
https://t.co/gF8grZFcoo

[Stanford RNA Medicine Program @StanfordRNAMed]

New research in @Nature shows mRNA vaccine CD8+ priming bypasses cDC1 cross-presentation. Non-hematopoietic cells act as primary transfectants; cDC2s acquire pMHC-I via IFN-I-dependent cross-dressing to drive robust CTL responses.
#mRNA #Immunology
https://t.co/G1XpE8ZzYI

[Stanford RNA Medicine Program @StanfordRNAMed]

New Phase 3 systems serology in Nature npj Vaccines: ARCT-154 (5 µg) sa-mRNA maintains superior neutralization & NK activation through Day 394 vs conventional mRNA. Prolonged antigen expression drives enhanced immune durability.
#mRNA #Vaccinology
https://t.co/UKXpecbAI9

[Stanford RNA Medicine Program @StanfordRNAMed]

New in @Nature Nanotechnology: Researchers used metal-ion-assisted RNA folding (MARF) to stabilize mRNA. Rigid architectures improved intracellular processing and boosted protein production 7.3-fold. #Nanotechnology #mRNA
https://t.co/MsDAwztb9Y

[Stanford RNA Medicine Program @StanfordRNAMed]

Phase I study in @Nature: individualized mRNA vaccines for early-stage TNBC, given with standard therapy, elicit durable CD4+/CD8+ T cell responses with persistent clonotypes. Early clinical signals show encouraging multi-year relapse-free outcomes.
#RNA
https://t.co/XEC4kRtndm

[Stanford RNA Medicine Program @StanfordRNAMed]

Segmented polyA tail design improves both template DNA stability and protein output from in vitro transcribed mRNA, per a recent Nucleic Acids Research study.
#biotech #RNAresearch
https://t.co/0O3pFtr1jN

[Stanford RNA Medicine Program @StanfordRNAMed]

"SOS splicing," reported in Nature, is a pathway in C. elegans and human cells that recognizes inverted terminal repeats and excises DNA transposons from mRNAs—buffering genes from TE insertions.
#RNA #Transposons
https://t.co/URsoDlFtBD

[Stanford RNA Medicine Program @StanfordRNAMed]

Why does loss of ADAR1 editing trigger immune activation?

@StanfordMed researchers identify a small, structural subset of endogenous dsRNAs that drive MDA5-mediated interferon signaling, refining understanding of #RNA sensing in autoimmunity.

https://t.co/FMRRxpgVx3